Business Wars   /     Sam Altman & the Battle for OpenAI | Blood in the Water

Summary

After five intense days, Sam Altman prevails over the OpenAI Board and is reinstated as CEO, with a new board in place.  But the turmoil has shown that OpenAI is vulnerable and its competitors, including Google and Microsoft, are ready to take advantage of OpenAI’s weakness.  And with OpenAI’s old board out and Chief Scientist Ilya Sutskever’s role at OpenAI murky, the path is clear for OpenAI to develop and commercialize AI at an even faster rate than as before.  See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Subtitle
Duration
00:35:36
Publishing date
2024-04-10 07:01
Contributors
Enclosures
https://dts.podtrac.com/redirect.mp3/chrt.fm/track/9EE2G/pdst.fm/e/rss.art19.com/episodes/78cd44f4-1fa9-4eba-8dc7-e89a84c86396.mp3?rss_browser=BAhJIgxNb3ppbGxhBjoGRVQ%3D--4f04cd103bfdd3e94cbbb356ead53321a4d63e94
audio/mpeg

Shownotes

After five intense days, Sam Altman prevails over the OpenAI Board and is reinstated as CEO, with a new board in place.  But the turmoil has shown that OpenAI is vulnerable and its competitors, including Google and Microsoft, are ready to take advantage of OpenAI’s weakness.  And with OpenAI’s old board out and Chief Scientist Ilya Sutskever’s role at OpenAI murky, the path is clear for OpenAI to develop and commercialize AI at an even faster rate than as before. 

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.